SCHEMBL5405308

SCHEMBL5405308

O=C(CCc1c[nH]c2c1CCCC2)N1CCOCC1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FKBP1A P62942 3/20 0.47
KMT2A Q03164 4/20 0.43
HSD17B10 Q99714 3/20 0.42
TSHR P16473 2/20 0.42
GAA P10253 1/20 0.42
ALOX15 P16050 1/20 0.42
ALDH1A1 P00352 4/20 0.42
MEN1 O00255 3/20 0.41
NPSR1 Q6W5P4 1/20 0.40
KDM4E B2RXH2 2/20 0.39
MAPT P10636 2/20 0.39
CASP1 P29466 1/20 0.39
CASP7 P55210 1/20 0.39
GLA P06280 1/20 0.39
TAAR1 Q96RJ0 1/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
HPGD P15428 1/20 0.39
NPC1 O15118 1/20 0.39
USP2 O75604 1/20 0.39
RAB9A P51151 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6299779 0.76 NPSR1 (0.42) KMT2AMEN1NPSR1KDM4EHPGD
SCHEMBL6691776 0.75 NPSR1 (0.41) KMT2ATSHRMEN1NPSR1KDM4E
SCHEMBL5402430 0.75 HTR1D (0.45) KMT2ATSHRALDH1A1KDM4ESMN1; SMN2
SCHEMBL24549755 0.72 HSD17B10 (0.48) FKBP1AKMT2AHSD17B10TSHRGAA
SCHEMBL5410458 0.72 HSD17B10 (0.42) FKBP1AKMT2AHSD17B10TSHRGAA
SCHEMBL5413673 0.70 KMT2A (0.50) KMT2AGAAALDH1A1MEN1KDM4E
SCHEMBL4410715 0.69 FKBP1A (0.50) FKBP1AKMT2AHSD17B10TSHRGAA
SCHEMBL12253782 0.68 SMN1; SMN2 (0.57) FKBP1AKMT2AHSD17B10GAAALDH1A1
SCHEMBL24549733 0.68 FKBP1A (0.51) FKBP1AHSD17B10TSHRGAAALOX15
SCHEMBL6613602 0.68 GAA (0.43) KMT2AGAAALDH1A1MEN1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7157577-B2 5-sulfonamido-substituted indolinone compounds as protein kinase inhibitors SUGEN INC. (US) 2007-01-02 US disclosed
US-20040266843-A1 Sulfonamide substituted indolinones as inhibitors of DNA dependent protein kinase (DNA-PK) SUGEN, INC. 2004-12-30 US disclosed
US-20040204407-A1 5-sulfonamido-substituted indolinone compounds as protein kinase inhibitors SUGEN INC. 2004-10-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040204407-A1 5-sulfonamido-substituted indolinone compounds as protein kinase inhibitors DMPK, MAP3K20, PHKG1 FKBP1A 663/4885KMT2A 2029/4885HSD17B10 2261/4885
US-20040266843-A1 Sulfonamide substituted indolinones as inhibitors of DNA dependent protein kinase (DNA-PK) CHEK2, CHEK1, ATM FKBP1A 847/4885KMT2A 991/4885HSD17B10 2552/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.